EUVIMEDEUVIMED entdecken
Crossref

Antitumor immune response elicited by M2 TAM-specific DDS via C-type lectin CD209b using cholesteryl pullulan nanogel as a protein drug carrier

Takaaki Nakatsukasa, Daisuke Muraoka, Situo Deng, Kiyoshi Yasui, Shin-Ichi Sawada, Asako Shimoda, Hirokazu Matsushita, Keitaro Matsumoto, Takeshi Nagayasu, Naozumi Harada, Kazunari Akiyoshi, Hiroaki Ikeda

Biomaterials Science · 2025

DOI: 10.1039/d5bm00342c ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2025. Verfasst von Takaaki Nakatsukasa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan. hikeda@nagasaki-u.ac.jp. Hauptthemen laut MEDLINE: Lectins, C-Type, Glucans, Drug Carriers, Receptors, Cell Surface. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mDC-SIGN (CD209b) is a promising target molecule for tumor-associated macrophage-specific drug delivery systems, and targeting this molecule could lead to the development of novel cancer therapies capable of efficiently delivering drugs to TAMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lectins, C-TypeGlucansDrug CarriersReceptors, Cell SurfaceNanogelsCell Adhesion MoleculesTumor-Associated MacrophagesExotoxinsBacterial ToxinsAntineoplastic AgentsAnimalsMiceHumansCell Line, TumorFemaleMice, Inbred BALB CDrug Delivery SystemsADP Ribose TransferasesDC-Specific ICAM-3 Grabbing Nonintegrin

Substanzen

Lectins, C-TypeGlucansDrug CarriersReceptors, Cell SurfaceNanogelsCell Adhesion MoleculesExotoxinsBacterial ToxinsAntineoplastic AgentsADP Ribose Transferases

Autor:innen und Institutionen

  • Department of Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan. hikeda@nagasaki-u.ac.jp.
  • Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan.
  • Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan. d.muraoka@aichi-cc.jp.
  • Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba 260-8670, Japan.
  • Department of Immunology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
  • The Hakubi Center for Advanced Research, Kyoto University, Kyoto, Japan.

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Nakatsukasa, T., Muraoka, D., Deng, S., Yasui, K., Sawada, S. I., Shimoda, A., Matsushita, H., Matsumoto, K., Nagayasu, T., Harada, N., Akiyoshi, K., & Ikeda, H. (2025). Antitumor immune response elicited by M2 TAM-specific DDS via C-type lectin CD209b using cholesteryl pullulan nanogel as a protein drug carrier. Biomaterials Science. https://doi.org/10.1039/d5bm00342c

Vancouver

Nakatsukasa T, Muraoka D, Deng S, Yasui K, Sawada SI, Shimoda A, et al. Antitumor immune response elicited by M2 TAM-specific DDS via C-type lectin CD209b using cholesteryl pullulan nanogel as a protein drug carrier. Biomaterials Science. 2025. doi:10.1039/d5bm00342c

BibTeX
@article{Nakatsukasa2025,
  author = {Nakatsukasa, Takaaki and Muraoka, Daisuke and Deng, Situo and Yasui, Kiyoshi and Sawada, Shin-Ichi and Shimoda, Asako and Matsushita, Hirokazu and Matsumoto, Keitaro and Nagayasu, Takeshi and Harada, Naozumi and Akiyoshi, Kazunari and Ikeda, Hiroaki},
  title = {Antitumor immune response elicited by M2 TAM-specific DDS via C-type lectin CD209b using cholesteryl pullulan nanogel as a protein drug carrier},
  journal = {Biomaterials Science},
  year = {2025},
  doi = {10.1039/d5bm00342c}
}
Kostenlos starten →